| Literature DB >> 397225 |
J P Brody, J H Binkley, S A Harding.
Abstract
Two commercially available rapid screening tests, Rubacell (Abbott Laboratories; passive hemagglutination) and FIAX (International Diagnostic Technology; indirect immunofluorescence) were compared with a standard hemagglutination inhibition assay for detection of immunity to rubella infection. In tests of approximately 300 sera, both rapid assays were specific and sensitive and showed a high predictive value of a positive result. Within-run reproducibility studies were excellent for both tests; however, Rubacell was superior to FIAX with respect to time-cost analysis.Entities:
Mesh:
Substances:
Year: 1979 PMID: 397225 PMCID: PMC273252 DOI: 10.1128/jcm.10.5.708-711.1979
Source DB: PubMed Journal: J Clin Microbiol ISSN: 0095-1137 Impact factor: 5.948